Fig 6.
Pre-treatment nomogram for predicting 5-year biochemical recurrence-free probability after radical prostatectomy including pre-operative plasma levels of transforming growth factor β1 and interleukin-6 soluble receptor. Reprinted with permission from Kattan et al [100].